Exercise as an Adjunctive Treatment for Cocaine Dependent Patients

Effectiveness of an Exercise Program in the Treatment of Cocaine Dependence

The purpose of this study is to evaluate if exercise added to usual treatment improves cocaine dependence treatment. The primary objective of this study is to investigate if exercise can facilitate cocaine craving reduction. The secondary aims are to evaluate if exercise can reduce negative mood states, improve quality of life and facilitate abstinence of cocaine.

Study Overview

Status

Completed

Conditions

Detailed Description

This study is designed as two-groups, randomized controlled trial to evaluate the effectiveness of an 8-week exercise program added to usual treatment compared with a health education program in 20 cocaine dependent patients. These participants will be randomized to one of the following two groups: a) exercise group: supervised moderate-vigorous exercise in group based on strength and calisthenics exercises, b) control group: supervised health education in group. All participants must have DSM-IV diagnosis of cocaine dependence as the primary disorder and must be in treatment.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08025
        • Hospital De La Santa Creu I Sant Pau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • DSM-IV diagnosis of cocaine dependence as primary disorder
  • age between 18 and 60 years
  • current psychosocial cocaine treatment

Exclusion Criteria:

  • medical problems that contraindicate the participation in an exercise program
  • family history of sudden death and/or early death due to cardiovascular reasons
  • current inclusion in a regular exercise program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise
Moderate-vigorous intensity strength exercise. 50 minutes per session, 2 times per week, 8 weeks.
Supervised moderate-vigorous exercise in group, based on strength and calisthenics exercises, 2 times per week during 8 weeks.
Active Comparator: Health education
Health education sessions. 50 minutes per session, 2 times per week, 8 weeks.
Supervised groups 2 times per week during 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Cocaine craving measured by means of a 5-item craving questionnaire (Roger D. Weiss)
Time Frame: weekly, up to 8 weeks
weekly, up to 8 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Mood states measured by Profile of Mood States (POMS)
Time Frame: weekly, up to 8 weeks
weekly, up to 8 weeks
Quality of life measured by 36-item Short-Form Survey (SF-36)
Time Frame: monthly, up to 2 months
monthly, up to 2 months
Change in Physical fitness (BMI, functional capacity and strength)
Time Frame: Change from Baseline Physical Fitness at 2 months
Change from Baseline Physical Fitness at 2 months
Percent days abstinent defined as the ratio between the number of negative cocaine urine test and the number of realised cocaine urine test
Time Frame: weekly, up to 8 weeks
weekly, up to 8 weeks
Change in cocaine craving measured by means of visual analogue scale (VAS)
Time Frame: Change from Baseline Cocaine Craving at 2 months
Change from Baseline Cocaine Craving at 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nuria Siñol Llosa, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

April 5, 2013

First Submitted That Met QC Criteria

April 12, 2013

First Posted (Estimate)

April 16, 2013

Study Record Updates

Last Update Posted (Estimate)

April 16, 2013

Last Update Submitted That Met QC Criteria

April 12, 2013

Last Verified

April 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • IIBSP-PEF-2011-98

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cocaine Dependence

Clinical Trials on Exercise

Subscribe